23948sdkhjf
Logga in eller skapa en prenumeration för att spara artiklar
Få tillgång till allt innehåll på Life Science Sweden
Ingen bindningstid eller kortinformation krävs
Gäller endast personlig prenumeration.
Kontakta oss för en företagslösning.
Annons
Annons

New antibody aims to slow kidney damage – “It’s kind of cool”

For 25 years, Marie Jeansson has studied the kidney and its blood vessels. She is now working on developing a drug intended to slow down chronic kidney disease.
Annons

Globally, more than 850 million people are estimated to suffer from chronic kidney disease. In Sweden, more than 10 percent of the population is believed to have some degree of this common condition, which can, for example, be caused by diabetes-related complications.

Many people are unaware that they have the disease, says Marie Jeansson, associate professor at Karolinska Institutet in Huddinge and Uppsala University, in an interview with Life Science Sweden.

Annons Annons
BREAKING
{{ article.headline }}
0.172|